Automated
image analysis is used by pharmaceutical companies to measure changes in cell
morphology, both rapidly and accurately. The field itself, dubbed High Content
Analysis (HCA) is emerging as one of the fastest growing sectors in drug
discovery and development. It represents the convergence between cell-based
assays, high-resolution imaging, and advanced quantitative image analysis.
There is no hard dividing line between High Content Screening (HCS) and HCA
though the former is generally higher-throughput while the latter has an
emphasis on gaining the maximum information from an assay, typically based on
images.
HCS systems achieve high throughput by rapidly capturing and processing
data from entire micro-well plates. Each well in these plates contains cells or
biochemical samples, which have been labeled to detect the changes induced by
perturbations, such as addition of a candidate drug compound or a gene
knockout. The images can be very dense, with hundreds of cells and complex cell
morphology. It may take several hours or even days to process the images
generated from a single experiment, which may be unacceptable in practice. The
ideal image processing time lies within the same time frame as the image
capturing. Read more>>>>>>>>>>>>

No comments:
Post a Comment